Latest Headlines

31. Results Of Nanoform Collaborative Study To Be Presented At U.S. Drug Delivery & Formulation (DDF) Summit 9/11/2025

    Nanoform, a leading nanoparticle medicine performance-enhancing company, announced that key findings from two studies conducted in collaboration between Nanoform and Takeda will be presented at the 15^th American Drug Delivery & Formulation Summit (DDF) in Boston, Mass., on September 16, 2025, at 09:10 – 09:40 in Room 1.

32. Ridge Biotechnologies Secures $25M Seed Funding To Pioneer AI-Powered Enzyme & Drug Design 9/11/2025

    Ridge Biotechnologies (Ridge Bio), a company pioneering enzyme and targeted drug design to power the next wave of precision medicines, emerged from stealth today with an oversubscribed $25 million in seed financing. Sutter Hill Ventures (SHV) incubated Ridge Bio and led the round, with participation from Overlap Holdings among others.

33. Proxio Group And Federal Equipment Announce Used Equipment Auction For September 25-30 9/10/2025

    Featuring 2022 Portland Kettleworks brewhouse, fermenters, and tanks – plus centrifuged, freeze dryers, incubators, and biotech lab.

34. New Hopewell NJ Facility Showcases Enzene's Continuous Manufacturing Platform 9/4/2025

    Governor Phil Murphy officially inaugurated the state-of-the-art biomanufacturing facility of Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO), marking a significant milestone in the expansion of global biotech capabilities in the United States.

35. Gilead Sciences Begins Construction On New Drug Manufacturing Facility In California 9/3/2025
36. Herma US To Exhibit Robotic Labeling Cell And Front/Back/Wrap Labeling Systems At Pack Expo 2025 9/3/2025
37. Amgen To Invest $600+ Million With New Science And Innovation Center In California 9/3/2025
38. CDMO Grand River Aseptic Manufacturing Announces Denis Johnson As New CEO 9/2/2025

    Grand River Aseptic Manufacturing (“GRAM” or the “Company”), a portfolio company of Arlington Capital Partners, today announced the promotion of Denis Johnson to Chief Executive Officer, effective September 1, 2025. Mr. Johnson has served as President of GRAM since March 31, 2025.

39. Meet With Bora At CPHI Frankfurt 2025 9/2/2025

    Meet with the Bora team during CPHI Frankfurt, October 28-30, to discuss how our drug product manufacturing expertise and recent capability investments can help accelerate your products and pipeline to commercial success.

40. Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture 9/2/2025

    Quotient Sciences announced a new partnership with the UK CPI (Centre for Process Innovation) to help accelerate mRNA therapeutics — combining CPI capabilities in LNP manufacturing and technology with Quotient Sciences' clinical and drug product development platform, Translational Pharmaceutics®.